Lie Deng | Oncology | Outstanding Contribution Award

Posted on by Innovator Awards

Mr.  Lie Deng | Oncology | Outstanding Contribution Award

Foshan institution of pathogenic microorganism | China

This academic summary highlights advanced expertise in medical research design, Oncology statistical analysis, biochemical and molecular biology techniques, cell culture methodologies, and bioinformatics, with a strong focus on respiratory syncytial virus research. The work emphasizes the development and optimization of molecular and immunological assays to support vaccine evaluation and translational research. Robust reverse transcription quantitative polymerase chain reaction and antibody enzyme linked immunosorbent assay methods were established to assess viral load and immune responses, providing reliable alternatives to commercially available detection systems while improving laboratory efficiency and accessibility. Comprehensive research efforts also include critical analysis of global vaccine development strategies, encompassing diverse technical routes such as live attenuated vaccines, subunit vaccines, vector based platforms, and nucleic acid approaches. These contributions integrate experimental data with comparative evaluation frameworks, offering valuable insights into vaccine design, efficacy assessment, and methodological standardization. In addition, the preparation of detailed molecular biology operation guidelines strengthened laboratory practices and ensured reproducibility of experimental workflows. Training activities focused on molecular cloning, polymerase chain reaction based assays, and data validation principles, supporting the development of independent experimental competence and high quality data generation. Overall, this body of work demonstrates a strong integration of experimental innovation, methodological rigor, and knowledge dissemination, contributing meaningfully to vaccine research, laboratory capacity building, and the advancement of evidence based evaluation methods in virology and immunological studies.

Profile: ORCID

Featured Publications 

Deng, L., Cao, H., Li, G., Zhou, K., Fu, Z., Zhong, J., Wang, Z., & Yang, X. (2025). Progress on respiratory syncytial virus vaccine development and evaluation methods. Vaccines, 13(3), 304.

Prof. Mrinal k ghosh  – Cancer Therapy – Outstanding Scientist Award

Posted on by Innovator Awards

Prof. Mrinal k ghosh  - Cancer Therapy - Outstanding Scientist Award

CSIR-Indian Institute of Chemical Biology - India 

Author Profile 

SCOPUS 

🎓 Early academic pursuits

Dr. Mrinal k ghosh earned his b.sc., m.sc., and phd in biochemistry from the university of calcutta, india. his academic journey was characterized by a strong foundation in molecular biology and biochemistry, leading to a prolific research career in cancer biology and inflammatory disorders.

🏢 Professional endeavors

Dr. Ghosh has held various prestigious positions at csir-indian institute of chemical biology, culminating in his current role as chief scientist. his international experience includes post-doctoral research at the cleveland clinic foundation, usa, and academic roles in india, contributing significantly to cancer research and molecular biology.

🔄 Contributions and research focus

Specializing in cancer biology and inflammatory disorders, dr. ghosh has developed groundbreaking research in signal transduction in cancer and stem cells. his work has led to numerous Cancer Therapy publications, patents, and collaborative projects that have advanced the understanding and treatment of cancer.

🏆 Accolades and recognition

His numerous accolades include the bharat vikash award, fellowships from the national academy of science and technology, and the outstanding scientist award. his role as a reviewer for top Cancer Therapy journals and evaluator for national and international projects further highlights his academic stature.

👨‍👩‍👦 Impact and influence

Dr. Ghosh's influence extends beyond his research, impacting policy-making, academic standards, and translational research in india. his leadership roles within csir-iicb and various academic Cancer Therapy committees have shaped the future of scientific research in the country.

🌟 Legacy and future contributions

Dr. Ghosh's legacy is defined by his contributions to cancer biology, his mentorship of future scientists, and his commitment to advancing biomedical research. his ongoing work promises continued innovation and significant contributions to cancer therapy and molecular biology.

Notable Publications 

  • Title: The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer
    Author(s): Gouranga Saha, Mrinal Kanti Ghosh
    Journal: BBA - Molecular Cell Research, 2025

  • Title: Phenolato and alkoxo promoted change in the ligand coordination mode in a four-membered ortho-metalated ruthenium(II) organometallics
    Author(s): Mrinal Kanti Ghosh, Jagannath Chowdhury, Purnananda Garu, Indranil Chakraborty, Swarup Chattopadhyay
    Journal: Polyhedron, 2025

  • Title: Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives
    Author(s): Sunny Kumar, Aafreen Ansari, Malini Basu, Sabana Begam, Mrinal Kanti Ghosh
    Journal: Advanced Therapeutics, 2025

  • Title: E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
    Author(s): Sunny Kumar, Malini Basu, Mrinal Kanti Ghosh
    Journal: BBA - Molecular Cell Research, 2024

  • Title: Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling
    Author(s): Mrinal Kanti Ghosh, Srija Roy
    Journal: Molecular Biomedicine, 2024

Prof Dr. Zhen Yang – Oncology and immunity – Young Scientist Award

Posted on by Innovator Awards

Prof Dr. Zhen Yang - Oncology and immunity - Young Scientist Award

Tianjin Union Medical Center of Nankai University - China

Author Profile 

ORCID

Early academic pursuits 🎓

Dr. Zhen Yang embarked on a journey in the medical field with a focus on understanding complex biological systems. With a Doctor of Medicine degree, Zhen cultivated a deep interest in the mechanisms of diseases, particularly malignant tumors. This foundation laid the groundwork for a career dedicated to advancing medical science and improving therapeutic strategies.

Professional endeavors 🏢

Currently, Zhen serves as a postdoctoral research fellow and a distinguished research fellow, overseeing laboratory technicians and guiding research initiatives. Zhen has played a crucial role in leading significant projects, including the National Natural Science Foundation of China and key initiatives from the Tianjin Health and Education Commissions. These positions reflect Zhen's leadership and commitment to fostering innovative research environments.

Contributions and research focus 🔬

Zhen's research primarily centers on immunotherapy for malignant tumors, integrating Chinese and Western medicine approaches. This unique perspective aims to enhance treatment efficacy and patient outcomes. With over ten published papers in prestigious journals, including Oncology and immunity Autophagy, Cancer Letters, and International Journal of Biological Macromolecules, Zhen's work significantly contributes to the scientific understanding of immunotherapeutic strategies and their applications in clinical settings.

Accolades and recognition 🏅

Zhen's contributions to medical research have not gone unnoticed, with recognition from various academic bodies and funding agencies. Leading projects funded by the National Natural Science Foundation of China and receiving support from Tianjin’s health and education sectors Oncology and immunity underscores Zhen's influence and reputation within the scientific community. Zhen’s work has been pivotal in advancing research methodologies and clinical applications in immunotherapy.

Impact and influence 🌍

The impact of Zhen Yang's research extends beyond academic publications, influencing clinical practices and therapeutic strategies for treating malignant tumors. By bridging traditional and modern medicine, Zhen's work fosters a holistic approach to cancer treatment, potentially Oncology and immunity transforming how therapies are designed and implemented. Zhen’s research serves as a valuable resource for other scientists and clinicians in the field.

Legacy and future contributions 🔮

Dr. Zhen Yang's legacy is one of innovation and dedication to improving cancer therapies. As research in immunotherapy continues to evolve, Zhen is poised to make further significant contributions that could redefine treatment paradigms. The integration of traditional and modern practices in Zhen's work promises to open new avenues for research and clinical application, ensuring a lasting impact on future generations of medical professionals and researchers.

Notable Publications

The METTL3/miR-196a Axis Predicts Poor Prognosis in Non-small Cell Lung Cancer  2024

Inflammatory factor TNFα-induced circDMD mediates R-loop formation to promote tumorigenesis 2024

β-Sitosterol Inhibits Tumor Growth and Amplifies Rituximab Sensitivity through Acid 2024

Effects of maternal advanced lipoxidation end products diet on the glycolipid metabolism 2024

EPYC functions as a novel prognostic biomarker for pancreatic cancer 2024